Listed by the USPTO as FERNANDEZ, SUSAN EMILY
Tech Center 1600 • Art Units: 1651 1653 1656 1682
This examiner grants 52% of resolved cases
Fernandez, Susan Emily, handles cases in Tech Center 1600 and Art Unit 1651. The record includes 566 resolved cases, with an allowance rate of 52.5% and a median of 1360 days to allowance. The interview lift is 60.7%, making interviews a major strategic consideration in a profile that also reflects a long prosecution path.
The listed companies are Cedars-Sinai Medical Center, The Regents of the University of California, and Nutricia. The leading firms are Nixon Peabody LLP, Leason Ellis LLP, and BANNER & WITCOFF, LTD. Practitioners should consider focused interview preparation, careful amendment planning, and realistic expectations for time to allowance.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18728813 | Listeria Variants and Methods of Use Thereof | Non-Final OA | The Regents of the University of California |
| 17572011 | PRODUCING METHOD FOR ORGANISM-DERIVED MATERIAL, PRODUCING METHOD FOR PRODUCT, AND VOLTAGE APPLYING DEVICE | Final Rejection | FUJIFILM Corporation |
| 18012059 | Concrete with Improved Environmental Impact | Final Rejection | Locus Solutions IPCo, LLC |
| 18845311 | METHODS AND COMPOSITIONS FOR SUPPRESSION OF BIOGENIC AMINES PRODUCED BY THE GUT MICROBIOME | Non-Final OA | Cedars-Sinai Medical Center |
| 17565834 | METHODS OF DIAGNOSIS, SELECTION, AND TREATMENT OF DISEASES AND CONDITIONS CAUSED BY OR ASSOCIATED WITH METHANOGENS | Final Rejection | Cedars-Sinai Medical Center |
| 19105296 | BIFIDOBACTERIUM BREVE, COMPOSITION COMPRISING BIFIDOBACTERIUM BREVE OR CULTURE THEREOF, AND USE OF BIFIDOBACTERIUM BREVE OR CULTURE THEREOF | Non-Final OA | TCI CO., LTD. |
| 18865063 | NOVEL LACTIC ACID BACTERIUM, AND COMPOSITION, FOOD OR BEVERAGE, AND PHARMACEUTICAL PRODUCT CONTAINING LACTIC ACID BACTERIUM | Non-Final OA | MITSUBISHI GAS CHEMICAL COMPANY, INC. |
| 18988370 | FREEZE-DRIED PROBIOTIC FOODSTUFFS | Non-Final OA | IMAGILIN TECHNOLOGY, LLC |
| 18835611 | LACTIC ACID BACTERIUM-CONTAINING TABLETS | Final Rejection | KIRIN HOLDINGS KABUSHIKI KAISHA |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy52.5% of resolved applications examined by Susan Emily Fernandez were allowed (566 resolved cases), compared with 31.5% across Art Unit 1651 over the last five years.
This examiner's interview lift is +60.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Susan Emily Fernandez took 1,360 days on average from filing to allowance.
Susan Emily Fernandez examines applications in Art Unit 1651 in Tech Center 1600 (Biotechnology & Pharmaceuticals).